In early stage Hodgkin's disease several factors have been shown to influence disease free survival after radiotherapy, most notably bulky intrathoracic disease, number of regions involved, stage, B-symptoms, ESR, histologic subtype, and sex. Most of these factors are likely to be related to the patient's total tumour burden. The patient's actual tumour burden, however, does not come out in the Ann Arbor staging system, since for the early stages this only distinguishes between one or several involved regions. It does not take tumour size into account, and lumps together quite large areas as one region, e.g. either side of the neck and the ipsilateral supraclavicular region.
The results of a recent smaller study seem to indicate that for the early stages of Hodgkin's disease a large tumour burden singles out patients destined to relapse after treatment with radiotherapy alone more accurately than other known prognostic factors (Specht & Nissen, 1986) . In the present article the prognostic significance of tumour burden and its relation to other known prognostic factors is examined in the total number of early stage patients who after randomization were treated with radiotherapy alone in the prospective Danish National Hodgkin Study (see below).
Patients and methods
Since 1971 all newly diagnosed previously untreated patients with Hodgkin's disease in Denmark have been centrally registered by the Danish National Hodgkin Study (LYGRA) and subjected to uniform staging procedures (conforming to the Ann Arbor classification (Carbone et al., 1971) ) and treatments. The diagnostic biopsies from all patients were reviewed by a panel of pathologists and classified in accordance with the method of Lukes and Butler (1966) were entered in a prospective study and randomized to receive either radiotherapy alone or radiotherapy plus adjuvant combination chemotherapy (Nissen & Nordentoft, 1982) . The 142 patients in the Danish National Hodgkin Study who received radiotherapy only and who had no intial extranodal manifestations form the study population.
Before radiotherapy was started all the involved peripheral lymph nodes of each of the 142 patients were measured and recorded. For (Specht & Nissen, 1986 (Peto et al., 1977) . To determine the independent contribution of each factor to prognosis a multivariate analysis using the model developed by Cox was used (Cox, 1972) .
Results
Tumour burden for all 142 patients is shown in Table I Figure 2 ). In both groups men have a slightly poorer disease free survival than women but in neither group does the difference reach statistical significance (P= 0.0798 and P = 0.1799 respectively). The difference in disease free survival between the 2 groups translates into a significant difference in survival from Hodgkin's disease (P=0.0025, Figure 3 ), whereas the difference in overall survival (including all causes of death) does not quite reach statistical significance (P=0.0579). The results of the present study confirm the findings of the above mentioned smaller-scale study (Specht & Nissen, 1986) to the effect that tumour burden is highly important, indeed probably the most important prognostic factor for patients in the early stages of Hodgkin's disease with regard to disease free survival after treatment with radiotherapy only. The concept of tumour burden combines the tumour size of each involved region with the number of involved regions. The number of involved regions has been shown by other studies to be of major prognostic significance (Tubiana et al., 1985; Liew et al., 1984; Thar et al., 1979; Leslie et al., 1985) . As demonstrated above, however, tumour burden offers some extra prognostic information. This is in accordance with the findings that local control by radiotherapy is poorer for large than for small tumours (Thar et al., 1979) , and that the presence of a large mass of lymph nodes adversely affects disease free survival after radiotherapy (Anderson et al., 1984) .
ESR has also been shown to be of major prognostic significance with regard to disease free survival (Tubiana et al., 1985; Haybittle et al., 1985) . Both of these studies, however, comprised both clinically and pathologically staged patients. In the present study ESR is clearly related to tumour burden and does not give significant independent prognostic information. Combining ESR with systemic symptoms as proposed by Tubiana et al. (1985) does not alter this.
Pathological stage is closely related to tumour burden and has no independent prognostic significance.
Mediastinal involvement, particularly bulky mediastinal involvement, has in many studies been shown to adversely influence disease free survival after radiotherapy (Nissen & Nordentoft, 1982; Liew et al., 1984; Thar et al., 1979; Leslie et al., 1985; Dorreen et al., 1984; Hoppe et al., 1982; Lee et al., 1980; Schomberg et al., 1984; Mauch et al., 1982) . In most earlier studies it has, however, not been taken into account that mediastinal involvement is rare in stage I whereas it is very common in stage II. Thus, in a recent study (Haybittle et al., 1985) it was found that clinical stage and mediastinal involvement gave similar prognostic information. In the present study mediastinal involvement and size are found to be closely related to tumour burden and to give no independent prognostic information.
Age has by others been found to be of prognostic significance in relation to Hodgkin's disease in general, especially in patients over the age of 50 (Wedelin et al., 1984) . In the present study age has no prognostic significance with regard to disease free survival, which may, however, be related to the fact that the large majority of patients are under 50 years of age.
The only factors of prognostic importance apart from tumour burden remaining after multivariate analysis are histologic subtype and sex.
As a result of modern therapeutic advances histologic subtype has in many studies in recent years shown a diminishing influence on prognosis in the sense that the difference in prognosis between NS and MC has been virtually eliminated in early stage disease (Kaplan, 1980a) . In the present study histologic subtype is a significant prognostic factor with LP having the best and MC the poorest disease free survival. NS has an intermediate disease free survival which in the final multivariate model is, however, neither significantly different from LP nor from MC.
Sex has a small but significant impact on disease free survival, which is in accordance with many earlier studies (Tubiana et al., 1985; Kaplan, 1980b) .
The combination of tumour burden and histologic subtype, the 2 factors with the greatest independent prognostic significance, makes it possible to single out more accurately than by any other prognostic factors a group of patients with a very poor disease free survival. These patients, comprising about 1/3 of the total number, also have a poor survival from Hodgkin's disease compared to the rest of the patients and are obviously candidates for additional initial treatment.
The results of the present study indicate that for the early stages of Hodgkin's disease, tumour burden assessed by the fairly simple method proposed above based on physical examination and ordinary chest radiographs is the single most important prognostic factor with regard to disease free survival after radiotherapy. Virtually all the hitherto known important prognostic factors are closely related to tumour burden and, hence, are of no independent prognostic significance. The combination of tumour burden and histologic subtype singles out patients destined to relapse after radiotherapy alone more accurately than any other known prognostic factor or combination of factors.
